Expand ARTL Menu
ARTL MENU

ARTL Stock Posts


ARTL #ArteloBiosciences stock declines -31.5% in premarket,

Premarket Decliner

ARTL Artelo Biosciences8.76-0.29-3.2%

Premarket:6.00-2.76 (-31.5%)

Artelo Biosciences Announces Proposed Underwritten Public Offering

Globe NewswireWed, 3-Sep 4:35 PM
ARTL #ArteloBiosciences stock declines -23.3% in after hours trading. See the latest news.

After Hours Decliner

ARTL Artelo Biosciences8.76-0.29-3.2%

After Hours:6.72-2.04 (-23.3%)

Artelo Biosciences Announces Proposed Underwritten Public Offering

Globe NewswireWed, 3-Sep 4:35 PM
ARTL #ArteloBiosciences stock declines -23.3% in after hours trading. See the latest news.

After Hours Decliner

ARTL Artelo Biosciences8.76-0.29-3.2%

After Hours:6.72-2.04 (-23.3%)

Artelo Biosciences Announces Proposed Underwritten Public Offering

Globe NewswireWed, 3-Sep 4:35 PM
ARTL #ArteloBiosciences stock declines -9.4% in premarket,

Premarket Decliner

ARTL Artelo Biosciences9.05-0.20-2.2%

Premarket:8.20-0.85 (-9.4%)

Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

Globe NewswireWed, 3-Sep 8:45 AM
ARTL #ArteloBiosciences stock increases 81.3% in premarket,

Premarket Gainer

ARTL Artelo Biosciences0.80+0.09+12.7%

Premarket:1.45+0.65 (+81.3%)

Artelo Biosciences Receives Ethics Approval to Commence its Cancer Appetite Recovery Phase I/II Clinical Study (CAReS) of ART27.13 for the Treatment of Cancer-Related Anorexia

Globe NewswireTue, 29-Sep 8:00 AM
ARTL stock increases 60.1% in premarket,

Premarket Gainer

ARTL Artelo Biosciences Inc.2.03-0.12-5.8%

Premarket:3.25+1.22 (+60.1%)

Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program

Globe NewswireMon, 3-Feb 8:30 AM
Load Earlier Posts
Market Data Delayed 15 Minutes